参考文献/References:
[1] GRECO F,VICENT M J.Polymer-drug conjugates: Current status and future trends[J].Frontiers in Bioscience,2008,13(1):2744-2756.
[2] BROXTERMAN H J,GEPRGOPAPADAKOU N H.Anticancer therapeutics: ″Addictive″ targets, multi-targeted drugs, new drug combinations[J].Drug Resistance Updates,2005,8(4):183-197.
[3] KLIMO P,CONNORS J M.MOPP/ABV hybrid program: Combination chemotherapy based on early introduction of seven effective drugs for advanced Hodgkin’s disease[J].Journal of Clinical Oncology,1985,3(9):1174-1182.
[4] DESALE S S,COHEN S M,ZHAO Y,et al.Biodegradable hybrid polymer micelles for combination drug therapy in ovarian cancer[J].Journal of Controlled Release,2013,171(3):339-348.
[5] JACK HU Che-ming,ZHANG Liang-fang.Nanoparticle-based combination therapy toward overcoming drug resistance in cancer[J].Biochemical Pharmacology,2012,83(8):1104-1111.
[6] LI Ming-jie,KIM J,LI S,et al.Long-term inhibition of HIV-1 infection in primary hematopoietic cells by lentiviral vector delivery of a triple combination of anti-HIV shRNA, anti-CCR5 ribozyme, and a nucleolar-localizing TAR decoy[J].Molecular Therapy,2005,12(5):900-909.
[7] FINZI D,BLANKSON J,SILICIANO J D,et al.Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy[J].Nature Medicine,1999,5(5):512-517.
[8] MEMVANGA P B,COCO R,PRÉAT V.An oral malaria therapy: Curcumin-loaded lipid-based drug delivery systems combined with β-arteether[J].Journal of Controlled Release,2013,172(3):904-913.
[9] EDAN G,MILLER D,CLANET M,et al.Therapeutic effect of mitoxantrone combined with methylprednisolone in multiple sclerosis: A randomised multicentre study of active disease using MRI and clinical criteria[J].Journal of Neurology, Neurosurgery & Psychiatry,1997,62(2):112-118.
[10] GHOFRANI H A,WIEDEMANN R,ROSE F,et al.Combination therapy with oral sildenafil and inhaled iloprost for severe pulmonary hypertension[J].Annals of Internal Medicine,2002,136(7):515-522.
[11] PRISANT L M,WEIR M R,PAPADEMETRIOU V,et al.Low-dose drug combination therapy: An alternative first-line approach to hypertension treatment[J].American Heart Journal,1995,130(2):359-366.
[12] SUAREZ-PINZON W L,POWER R F,YAN Y,et al.Combination therapy with glucagon-like peptide-1 and gastrin restores normoglycemia in diabetic NOD mice[J].Diabetes,2008,57(12):3281-3288.
[13] TARATULA O,KUZMOV A,SHAH M,et al.Nanostructured lipid carriers as multifunctional nanomedicine platform for pulmonary co-delivery of anticancer drugs and siRNA[J].Journal of Controlled Release, 2013, 171(3):349-357.
[14] SHIN H C,ALANI A W,RAO D A,et al.Multi-drug loaded polymeric micelles for simultaneous delivery of poorly soluble anticancer drugs[J].Journal of Controlled Release,2009,140(3):294-300.
[15] GRECO F,VICENT M J.Combination therapy: Opportunities and challenges for polymer-drug conjugates as anticancer nanomedicines[J].Advanced Drug Delivery Reviews,2009,61(13):1203-1213.
[16] CHEN Wei-guang,WANG Shi-bin.Research progress in co-delivery of gene and chemotherapy drugs with nanocarriers forcancertherapy [J].Acta Pharmaceutica Sinica,2013,48(7):1091-1098.
[17] VICENT M J,GRECO F,NICHOLSON R I,et al.Polymer therapeutics designed for a combination therapy of hormone-dependent cancer[J].Angewandte Chemie,2005,117(26):4129-4134.
[18] WU Wei-tai,SHEN Jing,BANERJEE P,et al.A multifuntional nanoplatform based on responsive fluorescent plasmonic ZnO-Au@ PEG hybrid nanogels[J].Advanced Functional Materials,2011,21(15):2830-2839.
[19] WANG Yin-song,CHEN Hong-li,LIU Yuan-yuan,et al.pH-sensitive pullulan-based nanoparticle carrier of methotrexate and combretastatin A4 for the combination therapy against hepatocellular carcinoma[J].Biomaterials,2013,34(29):7181-7190.
[20] LARSON N,GORMLEY A,FRAZIER N,et al.Synergistic enhancement of cancer therapy using a combination of heat shock protein targeted HPMA copolymer-drug conjugates and gold nanorod induced hyperthermia[J].Journal of Controlled Release,2013,170(1):41-50.
[21] SENGUPTA S,EAVARONE D,CAPILA I,et al.Temporal targeting of tumour cells and neovasculature with a nanoscale delivery system[J].Nature,2005,436(7050):568-572.
[22] HARE J I,MOASE E H,ALLEN T M.Targeting combinations of liposomal drugs to both tumor vasculature cells and tumor cells for the treatment of HER2-positive breast cancer[J].Journal of Drug Targeting,2013,21(1):87-96.
[23] ARYAL S,KEY J,STIGLIANO C,et al.Engineered magnetic hybrid nanoparticles with enhanced relaxivity for tumor imaging[J].Biomaterials,2013,34(31):7725-7732.
[24] AW M S,KURIAN M,LOSIC D.Polymeric micelles for multidrug delivery and combination therapy[J]. Chemistry-A European Journal,2013,19(38):12586-12601.
[25] HAN Ying-chao,HE Zhi-jian,SCHULZ A,et al.Synergistic combinations of multiple chemotherapeutic agents in high capacity poly(2-oxazoline)micelles[J].Molecular Pharmaceutics,2012,9(8):2302-2313.
[26] MI Yu, ZHAO Jing, FENG Si-shan.Targeted co-delivery of docetaxel, cisplatin and herceptin by Vitamin E TPGS-cisplatin prodrug nanoparticles for multimodality treatment of cancer[J].Journal of Controlled Release,2013,169(3):185-192.
[27] HE Qian-jun,GAO Yu,ZHANG Ling-xia,et al.A pH-responsive mesoporous silica nanoparticles-based multi-drug delivery system for overcoming multi-drug resistance[J].Biomaterials,2011,32(30):7711-7720.
[28] ACTON A L,FANTE C,FLATLEY B,et al.Janus PEG-based dendrimers for use in combination therapy:controlled multi-drug loading and sequential release[J].Biomacromolecules,2013,14(2):564-574.
[29] MENG Huan,MAI W X,ZHANG Hai-yuan,et al.Codelivery of an optimal drug/siRNA combination using mesoporous silica nanoparticles to overcome drug resistance in breast cancer in vitro and in vivo[J].ACS nano,2013,7(2):994-1005.
[30] ZHANG Hong-bin,ZHAO Chen,CAO Hui,et al.Hyperbranched poly(amine-ester)based hydrogels for controlled multi-drug release in combination chemotherapy[J].Biomaterials,2010,31(20):5445-5454.
[31] MA Jing,DU Lian-fang,CHEN Ming,et al.Drug loaded nano-microcapsules delivery system mediated by ultrasound targeted microbubble destruction: A promising therapy method(review)[J].Biomedical Reports,2013,1(4):506-510.
[32] LIU Liu,WU Qin-jie,MA Xue-lei,et al.Camptothecine encapsulated composite drug delivery system for colorectal peritoneal carcinomatosis therapy: Biodegradable microsphere in thermosensitive hydrogel[J].Colloids and Surfaces B: Biointerfaces,2013,106(1):93-101.
[33] SALAMA R O,YOUNG P M,TRAINI D.Concurrent oral and inhalation drug delivery using a dual formulation system: The use of oral theophylline carrier with combined inhalable budesonide and terbutaline[J].Drug Delivery and Translational Research,2013:1-12.
[34] MIAO W,SHIM G,LEE S,et al.Safety and tumor tissue accumulation of pegylated graphene oxide nanosheets for co-delivery of anticancer drug and photosensitizer[J].Biomaterials,2013,34(13):3402-3410.
[35] LIU Yuan-gang,SUN Xue-zhan,WANG Shi-bin,et al.Preparation of nanoparticles embedded microcapsules(NEMs)and their application in drug release[J].Materials Letters,2012,75(2):48-50.
[36] LIU Yuan-gang, MAO Hong-hao, WANG Shi-bin,et al.Preparation and characterization of a novel embolic nano-in-micro drug delivery system[J].Chemical Journal of Chinese Universites,2011,32(11):2574-2580.
[37] LIU Yuan-gang,ZHENG Qi-yao,WANG Shi-bin.Preparation and characterization of DHAD/HRP co-loaded multivesicular liposomes[J].Journal of Fiber Bioengineering and Informatics,2013,6(1):95-102.